Kintor Pharmaceutical Limited

Kintor Pharmaceutical Limited

KNTPF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$77.31M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Kintor Pharmaceutical LimitedKintor Pharmaceutical Limited-2.9--255%-1.2
$-0.04

Current Fair Value

124.1% downside

Overvalued by 124.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$77.31 Million
Enterprise Value$179.10 Million
Earnings per Share$-0.43
Beta-0.57
Outstanding Shares493,379,000

Return

Return on Equity-255.15%ROE
Return on Assets-87.38%
Return on Invested Capital-207.88%

Valuation & Multiples

P/E Ratio-2.88P/E Ratio
PEG-0.52PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue2.21
Enterprise Value to EBIT-0.63
Enterprise Value to Net Income-1
Total Debt to Enterprise0.75
Debt to Equity1.22Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
August 19, 2026
EPS
-$0.02
Reported
Revenue
$7.56 M
Reported

Next Earnings Call

Expected Date
April 1, 2027
EPS Estimate
-
Consensus analyst estimate
Revenue Estimate
-
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Kintor Pharmaceutical Limited

122 employees
CEO: Youzhi Tong

Kintor Pharmaceutical Limited, a biotechnology firm in its clinical development phase, is dedicated to the discovery, advancement, and marketing of a diverse array of small molecule and biological therapies. The company primarily concent...

Questions & Answers